Optical Spectroscopy as a Method for Skin Cancer Risk Assessment.

Eladio Rodriguez-Diaz¹, Danielle Manolakos², Holly Christman^3,4, Michael A Bonning^4,5, John K Geisse^3,6, Ousama M A'Amar¹, David J Leffell⁷, Irving J Bigio^1,8

¹Department of Biomedical Engineering, Boston University, Boston, MA.

²Gold Coast Dermatology Center, Delray Beach, FL.

³Department of Dermatology, University of California, San Francisco, San Francisco, CA.

⁴DermaSensor, Inc., Miami, FL.

⁵Department of Health Systems and Populations, Macquarie University, Sydney, NSW, Australia.

⁶Department of Pathology, University of California, San Francisco, San Francisco, CA.

⁷Yale University School of Medicine, New Haven, CT.

⁸Departments of Electrical & Computer Engineering, Physics, Medicine, Boston University, Boston, MA.

PubMed DOI

Abstract

Skin cancer is the most prevalent cancer, and its assessment remains a challenge for physicians. This study reports the application of an optical sensing method, elastic scattering spectroscopy (ESS), coupled with a classifier that was developed with machine learning, to assist in the discrimination of skin lesions that are concerning for malignancy. The method requires no special skin preparation…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.